UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000012175
Receipt No. R000014233
Scientific Title Phase II trial of Cisplatin and Irinotecan treatment as palliative-intended chemotherapy for previously untreated advanced thymic carcinoma
Date of disclosure of the study information 2013/11/30
Last modified on 2019/03/22 12:31:49

No. Disposal Last modified on Item of update
1 Insert 2013/10/30 20:56:36
2 Update 2013/11/29 14:05:53 Anticipated trial start date
3 Update 2013/11/29 14:07:00 Recruitment status
4 Update 2016/04/01 15:11:34 Name of primary sponsor
Organization
5 Update 2016/04/07 23:33:36 Name of primary sponsor
Organization
6 Update 2016/04/07 23:39:14 Name of primary sponsor
Organization
7 Update 2018/05/20 10:04:31 Recruitment status
8 Update 2019/03/22 12:29:07 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Organization
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
9 Update 2019/03/22 12:29:50 Date of IRB
Last follow-up date
Date of closure to data entry
10 Update 2019/03/22 12:31:49 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Results Delay Reason
Results Delay Reason
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.